Lash TL - Search Results

1

Triple-negative breast cancers are increased in black women regardless of age or body mass index.

Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, Blanchard RA, Lee JC, King TC, Rosenberg CL. Stead LA, et al. Among authors: lash tl. Breast Cancer Res. 2009;11(2):R18. doi: 10.1186/bcr2242. Epub 2009 Mar 25. Breast Cancer Res. 2009. PMID: 19320967 Free PMC article.

2

Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients.

Blackman SB, Lash TL, Fink AK, Ganz PA, Silliman RA. Blackman SB, et al. Among authors: lash tl. Cancer. 2002 Dec 15;95(12):2465-72. doi: 10.1002/cncr.10985. Cancer. 2002. PMID: 12467058 Free article.

3

Predictors and outcomes of surgeons' referral of older breast cancer patients to medical oncologists.

Thwin SS, Fink AK, Lash TL, Silliman RA. Thwin SS, et al. Among authors: lash tl. Cancer. 2005 Sep 1;104(5):936-42. doi: 10.1002/cncr.21256. Cancer. 2005. PMID: 15986400 Free PMC article.

4

Adherence to tamoxifen over the five-year course.

Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA. Lash TL, et al. Breast Cancer Res Treat. 2006 Sep;99(2):215-20. doi: 10.1007/s10549-006-9193-0. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541307

5

Risk of decline in upper-body function and symptoms among older breast cancer patients.

Westrup JL, Lash TL, Thwin SS, Silliman RA. Westrup JL, et al. Among authors: lash tl. J Gen Intern Med. 2006 Apr;21(4):327-33. doi: 10.1111/j.1525-1497.2006.00384.x. J Gen Intern Med. 2006. PMID: 16686807 Free PMC article.

6

Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women.

Owusu C, Lash TL, Silliman RA. Owusu C, et al. Among authors: lash tl. Breast Cancer Res Treat. 2007 Apr;102(2):227-36. doi: 10.1007/s10549-006-9321-x. Epub 2006 Sep 27. Breast Cancer Res Treat. 2007. PMID: 17004115

7

Modification of tamoxifen response: what have we learned?

Lash TL, Ahern TP, Cronin-Fenton D, Garne JP, Hamilton-Dutoit S, Kvistgaard ME, Rosenberg CL, Silliman RA, Sørensen HT. Lash TL, et al. J Clin Oncol. 2008 Apr 1;26(10):1764-5; author reply 1765-6. doi: 10.1200/JCO.2007.15.5432. J Clin Oncol. 2008. PMID: 18375910 No abstract available.

8

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.

Lash TL, Pedersen L, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT. Lash TL, et al. Br J Cancer. 2008 Aug 19;99(4):616-21. doi: 10.1038/sj.bjc.6604533. Epub 2008 Jul 29. Br J Cancer. 2008. PMID: 18665165 Free PMC article.

9

Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers.

Battaglia TA, Santana MC, Bak S, Gokhale M, Lash TL, Ash AS, Kalish R, Tringale S, Taylor JO, Freund KM. Battaglia TA, et al. Among authors: lash tl. Cancer. 2010 Feb 15;116(4):913-21. doi: 10.1002/cncr.24851. Cancer. 2010. PMID: 20052731 Free PMC article.

10

Evidence and practice regarding the role for CYP2D6 inhibition in decisions about tamoxifen therapy.

Lash TL, Rosenberg CL. Lash TL, et al. J Clin Oncol. 2010 Mar 10;28(8):1273-5. doi: 10.1200/JCO.2009.26.7906. Epub 2010 Feb 1. J Clin Oncol. 2010. PMID: 20124162 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page